As of 2025-06-01, the Intrinsic Value of Aethlon Medical Inc (AEMD) is -3.50 USD. This AEMD valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.37 USD, the upside of Aethlon Medical Inc is -1,036.41%.
Based on its market price of 0.37 USD and our intrinsic valuation, Aethlon Medical Inc (AEMD) is overvalued by 1,036.41%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -3.50 - -3.50 | -3.50 | -1,036.41% |
| P/E | (22.75) - (25.64) | (23.83) | -6472.2% |
| DDM - Stable | (11.08) - (141.61) | (76.34) | -20512.4% |
| DDM - Multi | (12.01) - (118.76) | (21.77) | -5921.5% |
| Market Cap (mil) | 6.02 |
| Beta | 1.50 |
| Outstanding shares (mil) | 16.09 |
| Enterprise Value (mil) | 1.19 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.44% |
| Cost of Debt | 5.00% |
| WACC | 5.05% |